1159512-68-1 Usage
General Description
1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE is a chemical compound consisting of a benzene ring with two bromine atoms and one trifluoromethyl group attached. It is commonly used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. The compound is known for its high reactivity and is often used as a reagent in organic synthesis. It is also used as a building block in the production of specialty chemicals and materials. Additionally, the compound has potential applications in the field of organic electronics and photovoltaics due to its electronic properties. Overall, 1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE is a versatile and important chemical in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1159512-68-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,9,5,1 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1159512-68:
(9*1)+(8*1)+(7*5)+(6*9)+(5*5)+(4*1)+(3*2)+(2*6)+(1*8)=161
161 % 10 = 1
So 1159512-68-1 is a valid CAS Registry Number.
1159512-68-1Relevant articles and documents
AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE
-
, (2021/10/15)
Relating to a compound represented by formula (I) and a pharmaceutically acceptable salt of the compound, and an application of the compound as an S1P1 agonist.
Modulators of the nuclear hormone receptor ROR
-
Page/Page column 162; 163, (2017/03/28)
The invention provides small molecule modulators of retinoic acid receptor-related orphan receptors such as RORα, RORβ, or RORγ, of formula with the variable atoms as defined herein and R1 comprising a hydroxyl- or alkoxyl-substituted fluoroalkyl group. Compounds of the invention can be effective modulators at concentrations ineffective to act on LXR receptors, or on other nuclear receptors, or other biological targets. Methods of modulation the RORs and methods of treating metabolic disorders, immune disorders, cancer, and CNS disorders wherein modulation of an ROR is medically indicated are also provided.